Clinical trials
Recruiting Phase 1 Cardiovascular Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dr. B. Catharine. Craven | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Kalie Tommerdahl | 1 |
| Monash University | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| OriCell Therapeutics Co., Ltd. | 1 |
| Rocket Pharmaceuticals Inc. | 1 |
| The University of Texas Health Science Center at San Antonio | 1 |
| University of Alberta | 1 |
| University of California, Davis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 14 |
| Atherosclerosis | 3 |
| Hypertension | 2 |
| Vascular Diseases | 2 |
| Blood Protein Disorders | 1 |
| Body Weight | 1 |
| Bone Diseases | 1 |
| Cardiomegaly | 1 |
| Cardiomyopathies | 1 |
| Cardiomyopathy, Dilated | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.